Nashville, Tennessee, US: Cryoport has acquired Critical Transport Solutions Australia for US$5million.
It will continue to be run by the current management team but as part of a Cryoport business unit, Cryopdp.
The acquisition improves Cryoport’s Asia Pacific presence at a time when the number of clinical trials taking place in the region is increasing. “Adding this new country into Cryopdp’s global network will enable the Cryoport Group of companies to develop additional synergies in this specific country, providing end-to-end pharma/biopharma logistics solutions to our global customers and the local players in Australia, Cedric Picaud, chief executive, Cryopdp, said.
“By this additional geographical coverage, we are also anticipating the fast growing needs of our top strategic customers, to better serve their expanded activities in this zone and to be always closer to patients. As a strong customer and patient centric organization our strategy is to continue to develop our geographical footprint,” he said.